 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Adaptimmune Therapeutics PLC (ADAP)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-08-06 Sale | 2019-08-07 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Amado Rafael President | 11,043 | $2.06 | $22,749 | 17,237 (Direct) | View |
| 2019-01-14 Sale | 2019-01-16 9:31 pm | Adaptimmune Therapeutics PLC | ADAP | Binder-Scholl Gwendolyn Knowlton CTO | 1,514 | $5.369 | $8,129 | 2,487 (Direct) | View |
| 2019-01-14 Sale | 2019-01-16 9:31 pm | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR COO | 2,271 | $5.369 | $12,194 | 3,731 (Direct) | View |
| 2019-01-14 Sale | 2019-01-16 9:31 pm | Adaptimmune Therapeutics PLC | ADAP | Amado Rafael President | 3,028 | $5.369 | $16,259 | 4,974 (Direct) | View |
| 2019-01-14 Sale | 2019-01-16 9:30 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian CFO | 3,084 | $5.369 | $16,559 | 3,318 (Direct) | View |
| 2018-12-17 Purchase | 2018-12-19 8:04 pm | Adaptimmune Therapeutics PLC | ADAP | Alleva Lawrence M Director | 47,280 | $0.84 | $39,715 | 70,584 (Direct Indirect) | View |
| 2018-09-07 Purchase | 2018-09-10 4:49 pm | Adaptimmune Therapeutics PLC | ADAP | Viswanathan Ravi 10% Owner | 15,000,000 | $1.667 | $25,000,500 | 82,978,672 (Indirect) | View |
| 2018-09-07 Purchase | 2018-09-10 4:49 pm | Adaptimmune Therapeutics PLC | ADAP | Sonsini Peter W. 10% Owner | 15,000,000 | $1.667 | $25,000,500 | 82,978,672 (Indirect) | View |
| 2018-09-07 Purchase | 2018-09-10 4:49 pm | Adaptimmune Therapeutics PLC | ADAP | SANDELL SCOTT D 10% Owner | 15,000,000 | $1.667 | $25,000,500 | 82,978,672 (Indirect) | View |
| 2018-09-07 Purchase | 2018-09-10 4:48 pm | Adaptimmune Therapeutics PLC | ADAP | MOTT DAVID M Director, 10% Owner | 15,000,000 | $1.667 | $25,000,500 | 82,978,672 (Indirect) | View |
| 2018-09-07 Purchase | 2018-09-10 4:48 pm | Adaptimmune Therapeutics PLC | ADAP | KERINS PATRICK J 10% Owner | 3,000,000 | $1.667 | $5,000,100 | 82,978,672 (Indirect) | View |
| 2018-09-07 Purchase | 2018-09-10 4:47 pm | Adaptimmune Therapeutics PLC | ADAP | Florence Anthony A. Jr. 10% Owner | 15,000,000 | $1.667 | $25,000,500 | 82,978,672 (Indirect) | View |
| 2018-09-07 Purchase | 2018-09-10 4:47 pm | Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director | 12,000,000 | $1.667 | $20,000,400 | 12,000,000 (Indirect) | View |
| 2018-09-07 Purchase | 2018-09-10 4:46 pm | Adaptimmune Therapeutics PLC | ADAP | BASKETT FOREST 10% Owner | 15,000,000 | $1.667 | $25,000,500 | 82,978,672 (Indirect) | View |
| 2018-09-07 Purchase | 2018-09-10 4:46 pm | Adaptimmune Therapeutics PLC | ADAP | BARRIS PETER J 10% Owner | 15,000,000 | $1.667 | $25,000,500 | 82,978,672 (Indirect) | View |
| 2018-09-07 Purchase | 2018-09-10 4:45 pm | Adaptimmune Therapeutics PLC | ADAP | BARRETT M JAMES 10% Owner | 3,000,000 | $1.667 | $5,000,100 | 82,978,672 (Indirect) | View |
| 2018-09-07 Purchase | 2018-09-10 4:45 pm | Adaptimmune Therapeutics PLC | ADAP | New Enterprise Associates 14 L.P. NEA Partners 14 L.P. NEA 14 GP LTD 10% Owner | 3,000,000 | $1.667 | $5,000,100 | 82,978,672 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-09-01 Option Award | 2019-09-03 9:00 pm | N/A 2029-09-01 | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian CFO, CEO | 628,872 | $0.27 | 628,872 (Direct) | View |
| 2019-09-01 Option Award | 2019-09-03 9:00 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian CFO, CEO | 140,448 | $0.0012 | 628,872 (Direct) | View |
| 2019-08-01 Option Award | 2019-08-05 9:03 pm | N/A 2029-08-01 | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 839,568 | $0.55 | 839,568 (Direct) | View |
| 2019-08-01 Option Award | 2019-08-05 9:03 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 187,500 | $0.0012 | 839,568 (Direct) | View |
| 2019-07-02 Option Award | 2019-07-03 5:41 pm | 2020-07-20 2029-07-02 | Adaptimmune Therapeutics PLC | ADAP | MOTT DAVID M Director, 10% Owner | 350,947 | $0.61 | 350,947 (Direct) | View |
| 2019-07-02 Option Award | 2019-07-03 5:40 pm | 2020-07-02 2029-07-02 | Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director | 234,407 | $0.61 | 234,407 (Direct) | View |
| 2019-07-02 Option Award | 2019-07-03 5:01 pm | 2020-07-02 2029-07-02 | Adaptimmune Therapeutics PLC | ADAP | Zaks Tal Zvi Director | 124,000 | $0.61 | 124,000 (Direct) | View |
| 2019-07-02 Option Award | 2019-07-03 5:00 pm | 2020-07-02 2029-07-02 | Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director | 234,407 | $0.61 | 234,407 (Direct) | View |
| 2019-07-02 Option Award | 2019-07-03 5:00 pm | 2020-07-02 2029-07-02 | Adaptimmune Therapeutics PLC | ADAP | Furey John Director | 240,541 | $0.61 | 240,541 (Direct) | View |
| 2019-07-02 Option Award | 2019-07-03 5:00 pm | 2020-07-02 2029-07-02 | Adaptimmune Therapeutics PLC | ADAP | Kerr Giles Francis Bertram Director | 124,000 | $0.61 | 124,000 (Direct) | View |
| 2019-07-02 Option Award | 2019-07-03 5:00 pm | 2020-07-02 2029-07-02 | Adaptimmune Therapeutics PLC | ADAP | Duncan Barbara Gayle Director | 124,000 | $0.61 | 124,000 (Direct) | View |
| 2019-07-02 Option Award | 2019-07-03 5:00 pm | 2020-07-02 2029-07-02 | Adaptimmune Therapeutics PLC | ADAP | Alleva Lawrence M Director | 271,209 | $0.61 | 271,209 (Direct) | View |
| 2019-06-27 Option Award | 2019-06-27 8:00 pm | N/A 2029-06-27 | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian CFO | 628,872 | $0.68 | 628,872 (Direct) | View |
| 2019-06-27 Option Award | 2019-06-27 8:00 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian CFO | 140,448 | $0.0013 | 628,872 (Direct) | View |
| 2019-05-16 Exercise | 2019-05-17 6:00 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | Noble James CEO | 1,773,100 | $0.143 | 12,945,700 (Direct) | View |
| 2019-01-04 Option Award | 2019-01-08 9:02 pm | N/A 2029-01-04 | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR COO | 1,006,224 | $0.89 | 1,006,224 (Direct) | View |
| 2019-01-04 Option Award | 2019-01-08 9:02 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR COO | 224,724 | $0.0013 | 1,006,224 (Direct) | View |
| 2019-01-04 Option Award | 2019-01-08 9:01 pm | N/A 2029-01-04 | Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business Officer | 1,006,224 | $0.89 | 1,006,224 (Direct) | View |
| 2019-01-04 Option Award | 2019-01-08 9:01 pm | N/A 2029-01-04 | Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business Officer | 224,724 | $0.0013 | 1,006,224 (Direct) | View |
| 2019-01-04 Option Award | 2019-01-08 9:01 pm | N/A 2029-01-04 | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian CFO | 1,257,744 | $0.89 | 1,257,744 (Direct) | View |
| 2019-01-04 Option Award | 2019-01-08 9:01 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian CFO | 280,896 | $0.0013 | 1,257,744 (Direct) | View |
| 2019-01-04 Option Award | 2019-01-08 9:01 pm | N/A 2029-01-04 | Adaptimmune Therapeutics PLC | ADAP | Amado Rafael President | 1,006,224 | $0.89 | 1,006,224 (Direct) | View |
| 2019-01-04 Option Award | 2019-01-08 9:01 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | Amado Rafael President | 224,724 | $0.0013 | 1,006,224 (Direct) | View |
| 2019-01-04 Option Award | 2019-01-08 9:00 pm | N/A 2029-01-04 | Adaptimmune Therapeutics PLC | ADAP | Noble James CEO | 2,515,536 | $0.89 | 2,515,536 (Direct) | View |
| 2019-01-04 Option Award | 2019-01-08 9:00 pm | N/A 2029-01-04 | Adaptimmune Therapeutics PLC | ADAP | Noble James CEO | 561,792 | $0.0013 | 2,515,536 (Direct) | View |
| 2018-10-01 Sale | 2018-10-02 7:58 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | Binder-Scholl Gwendolyn Knowlton CTO | 25,000 | $13.79 | 0 (Direct) | View |
| 2018-08-29 Sale | 2018-08-31 8:02 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | Binder-Scholl Gwendolyn Knowlton CTO | 25,000 | $10.25 | 0 (Direct) | View |
| 2018-08-06 Option Award | 2018-08-07 5:14 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | Amado Rafael President | 678,720 | $0.0013 | 678,720 (Direct) | View |
| 2018-06-22 Option Award | 2018-06-26 5:07 pm | 2019-06-22 2028-06-22 | Adaptimmune Therapeutics PLC | ADAP | MOTT DAVID M Director, 10% Owner | 187,330 | $2.18 | 187,330 (Direct) | View |
| 2018-06-22 Option Award | 2018-06-26 5:05 pm | 2019-06-22 2028-06-22 | Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director | 154,809 | $2.18 | 154,809 (Direct) | View |
| 2018-06-22 Option Award | 2018-06-26 5:01 pm | 2019-06-22 2028-06-22 | Adaptimmune Therapeutics PLC | ADAP | Zaks Tal Zvi Director | 124,000 | $2.18 | 124,000 (Direct) | View |